The impact of social vulnerability index on survival following autologous stem cell transplant for multiple myeloma

Bone Marrow Transplantation

by Kiarash Salafian, Christine Mazimba, Leonid Volodin, Indumathy Varadarajan, Asal Pilehvari, Wen You, Ziyad O. Knio, Karen Ballen
January 18, 2024

Blood Cancer Journal (Nature Portfolio)

Enterocolitis Associated with Immune Effector Cells Following BCMA-Targeted CAR T-Cell Therapy: Findings from a Multicenter Case Series

by Sandra Susanibar-Adaniya, Benjamin A. Derman, Adam D. Cohen, Dan T. Vogl, Shambavi Richard, Adriana Rossi, Matthew J. Frigualt, Andrew J. Yee, Binod Dhakal, Noffar Bar
April 28, 2026

Frontiers In Immunology

Why are long-lived plasma cells long-lived?

by Julia Grace Reinke, Christopher Schorr, Kelvin Paul Lee
May 7, 2026

The Medicine Maker

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

May 12, 2026
7 min

The impact of social vulnerability index on survival following autologous stem cell transplant for multiple myeloma

Original Source(s)

The impact of social vulnerability index on survival following autologous stem cell transplant for multiple myeloma

Related Content

Enterocolitis Associated with Immune Effector Cells Following BCMA-Targeted CAR T-Cell Therapy: Findings from a Multicenter Case Series

Why are long-lived plasma cells long-lived?

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push